The embers of resistance – in Gaza, Iraq, Lebanon, Syria, Yemen - have not been snuffed out. With the attack on Iran, they are being fanned into a fire Protesters burn pictures of Donald Trump and ...
Taysha Gene Therapies (TSHA) reported a net loss of $109.0 million for the full year ending December 31, 2025, translating to a loss of $0.34 per share. This marks an increase from the $89.3 million ...
DALLAS, March 19, 2026 (GLOBE NEWSWIRE)-- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus ...
The GloMax ® Explorer is a high-performance multimode detection instrument that allows you to get up and running quickly, generating the data you need from your experiments. Simply unpack it, plug it ...
Good day, and thank you for standing by. Welcome to the Taysha Gene Therapies Full Year 2025 Financial Results Conference Call. [Operator Instructions] Please be advised that today's conference is ...
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q4 2025 Earnings Call Transcript March 19, 2026 Taysha Gene Therapies, Inc. beats earnings expectations. Reported EPS is $-0.08711, expectations were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results